Tuvorilimab
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Tuvorilimab, covering 2025-12-30 to 2025-12-30. Get the full timeline:
Most recent: Clinical Trial Update: Gemcitabine and Nab-Paclitaxel Combined With Iparomlimab and Tuvorilimab for Advanced Gallbladder Cancer [Phase 2]